You are viewing issue# 887

Just around the corner: FTC lawsuits targeting native ads

In the two years since the Federal Trade Commission held a daylong workshop that focused on the increasingly blurred lines between advertisements and independent editorial content in digital media, marketing executives, lobbyists and publishers have awaited, somewhat anxiously, for the agency’s next move.

Read More

Taking the humble approach: An in-depth Q&A with Maureen Ohlhausen

Federal Trade Commission member Maureen Ohlhausen thinks that regulators are at their best when they approach issues with humility. As the panel’s lone Republican (a seat on the commission is...

It’s a women’s world at the FTC

Former Federal Trade Commission member Joshua Wright was barely out of the building in August when the women he left behind — the four remaining commissioners at the agency — noted with some degree...

New prescriptions proposed for Eyeglass Rule

About 158 million Americans wear glasses, so it’s not surprising that Federal Trade Commission officials are seeing double in the wake of a request for public comments on proposed changes to the...

Defense Department seeking more power on defense industry deals

There could be another federal department entering the antitrust turf war and this one is the governmental equivalent of the proverbial 800-pound gorilla.

Critics take aim at FTC report that puts companies on notice about wrongful use of Big Data

Sixteen months ago, the Federal Trade Commission held a workshop on “Big Data: A Tool for Inclusion or Exclusion” that examined the impact of the immense collection and analysis of data on...

Neil Averitt commentary: Yeehaw! Antitrust claims hit the rodeo world

The world of calf-roping, bronc riding, and bulldogging seems about as far from the fogs of antitrust law as it is possible to get. But the management and sanctioning of rodeos is big business —...

FTC cracking down on apps promising brain improvements

Brill statements show emerging divide over repeal of state healthcare laws

FTC, DOJ look at availability of other remedies when deciding whether to seek disgorgement

FTC staff recommends approval of Ball-Rexam deal